Trials / Sponsors / Bradley A. McGregor, MD
Bradley A. McGregor, MD
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Avelumab, Palbociclib and Axitinib in Advanced RCC Advanced Clear Cell Renal Cell Carcinoma | Phase 2 | 2024-05-31 |
| Active Not Recruiting | Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC Papillary Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Translocation Renal Cell Carcinoma | Phase 2 | 2020-11-05 |
| Completed | Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2017-08-01 |